These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 3446868
21. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator. Hsu MM, Chiou CR, Ko JY, Sheen TS, Hong RL, Ting LL. Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131 [Abstract] [Full Text] [Related]
29. Flow cytometric evaluation of early invasive cervical cancer. Connor JP, Miller DS, Bauer KD, Murad TM, Rademaker AW, Lurain JR. Obstet Gynecol; 1993 Mar 15; 81(3):367-71. PubMed ID: 8437788 [Abstract] [Full Text] [Related]
30. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors. el-Naggar AK, Hurr K, Tu ZN, Teague K, Raymond KA, Ayala AG, Murray J. Cytometry; 1995 Mar 01; 19(3):256-62. PubMed ID: 7736870 [Abstract] [Full Text] [Related]
31. Cell proliferation in childhood acute leukemia. Comparison of Ki-67 and proliferating cell nuclear antigen immunocytochemical and DNA flow cytometric analysis. Ito M, Tsurusawa M, Zha Z, Kawai S, Takasaki Y, Fujimoto T. Cancer; 1992 Apr 15; 69(8):2176-82. PubMed ID: 1347483 [Abstract] [Full Text] [Related]
32. [Changes in the stability of the parameters of the bone marrow cell cycle in hematologic diseases]. Shmarov DA, Kuchma IuM, Kozinets GI. Ter Arkh; 1997 Apr 15; 69(7):17-21. PubMed ID: 9424752 [Abstract] [Full Text] [Related]
34. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia. Hans CP, Finn WG, Singleton TP, Schnitzer B, Ross CW. Am J Clin Pathol; 2002 Feb 15; 117(2):301-5. PubMed ID: 11863227 [Abstract] [Full Text] [Related]
35. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia. Zelezníková T, Babusíková O. Neoplasma; 2006 Feb 15; 53(6):500-6. PubMed ID: 17167719 [Abstract] [Full Text] [Related]
36. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A. Creutzig U, Büchner T, Sauerland MC, Zimmermann M, Reinhardt D, Döhner H, Schlenk RF. Cancer; 2008 Feb 01; 112(3):562-71. PubMed ID: 18076087 [Abstract] [Full Text] [Related]
37. Cell kinetics and prognosis in acute leukemia studied by DNA cytofluorometry. Shimazaki C, Nishio A, Haruyama H, Isemura T, Nakagawa M, Ijichi H. Nihon Ketsueki Gakkai Zasshi; 1986 Feb 01; 49(1):70-9. PubMed ID: 3705894 [No Abstract] [Full Text] [Related]
38. Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia. Liso V, Albano F, Pastore D, Carluccio P, Mele G, Lamacchia M, Mestice A, Specchia G. Haematologica; 2000 Dec 01; 85(12):1285-90. PubMed ID: 11114136 [Abstract] [Full Text] [Related]
39. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations. Lindahl B, Alm P, Killander D, Långström E, Tropé C. Anticancer Res; 1987 Dec 01; 7(4B):781-9. PubMed ID: 3674763 [Abstract] [Full Text] [Related]
40. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Hedley DW, Rugg CA, Gelber RD. Cancer Res; 1987 Sep 01; 47(17):4729-35. PubMed ID: 3621170 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]